Gene · 970
Papers4,349
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,861 to 1,880 of 4,349
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dissecting Tumor Antigens and Immune Subtypes of Glioma to Develop mRNA Vaccine. | Front Immunol | 2021 | 34512630 | PubTator, text mining | PubMed |
| Immune-Omics Networks of CD27, PD1, and PDL1 in Non-Small Cell Lung Cancer. | Cancers (Basel) | 2021 | 34503105 | PubTator, text mining | PubMed |
Hypofractionated Radiotherapy Upregulates Several Immune Checkpoint Molecules in Head and Neck Squamous Cell Carcinoma Cells Independently of the HPV Status While ICOS-L Is Upregulated Only on HPV-Positive Cells. | Int J Mol Sci | 2021 | 34502022 | PubTator, text mining | PubMed |
| Pathogenic T Cells in Celiac Disease Change Phenotype on Gluten Challenge: Implications for T-Cell-Directed Therapies. | Adv Sci (Weinh) | 2021 | 34495570 | PubTator, text mining | PubMed |
| A single-cell and spatially resolved atlas of human breast cancers. | Nat Genet | 2021 | 34493872 | PubTator, text mining | PubMed |
| CD19-directed CAR T-cell therapy for treatment of primary CNS lymphoma. | Blood Adv | 2021 | 34492703 | PubTator, text mining | PubMed |
| Immune classifier-based signatures provide good prognostic stratification and predict the clinical benefits of immune-based therapies for hepatocellular carcinoma. | Cancer Cell Int | 2021 | 34488768 | PubTator, text mining | PubMed |
| The immune microenvironment in EGFR- and ERBB2-mutated lung adenocarcinoma. | ESMO Open | 2021 | 34487971 | PubTator, text mining | PubMed |
| Characterizing and understanding the formation of cysteine conjugates and other by-products in a random, lysine-linked antibody drug conjugate. | MAbs | 2021 | 34486490 | PubTator, text mining | PubMed |
| Characterizing the cellular immune response to subretinal AAV gene therapy in the murine retina. | Mol Ther Methods Clin Dev | 2021 | 34485594 | PubTator, text mining | PubMed |
| Recent Progress on Primary Central Nervous System Lymphoma-From Bench to Bedside. | Front Oncol | 2021 | 34485125 | PubTator, text mining | PubMed |
| Identification of a Costimulatory Molecule-Related Signature for Predicting Prognostic Risk in Prostate Cancer. | Front Genet | 2021 | 34484286 | PubTator, text mining | PubMed |
| Hallmarks of Cancers: Primary Antibody Deficiency Versus Other Inborn Errors of Immunity. | Front Immunol | 2021 | 34484227 | PubTator, text mining | PubMed |
| Co-Stimulatory Bispecific Antibodies Induce Enhanced T Cell Activation and Tumor Cell Killing in Breast Cancer Models. | Front Immunol | 2021 | 34484225 | PubTator, text mining | PubMed |
| Neuroinflammation in Autoimmune Disease and Primary Brain Tumors: The Quest for Striking the Right Balance. | Front Cell Neurosci | 2021 | 34483843 | PubTator, text mining | PubMed |
| Anti-tumour necrosis factor α antibodies and circulating lymphocyte phenotypes in inflammatory bowel disease. | Int Immunopharmacol | 2021 | 34461492 | PubTator, text mining | PubMed |
| B7 homologue 3 as a prognostic biomarker and potential therapeutic target in gastrointestinal tumors. | World J Gastrointest Oncol | 2021 | 34457187 | PubTator, text mining | PubMed |
| Nanoradiopharmaceuticals Based on Alpha Emitters: Recent Developments for Medical Applications. | Pharmaceutics | 2021 | 34452084 | PubTator, text mining | PubMed |
| Contribution of the Commensal Microflora to the Immunological Homeostasis and the Importance of Immune-Related Drug Development for Clinical Applications. | Int J Mol Sci | 2021 | 34445599 | PubTator, text mining | PubMed |
| Antibody Conjugates for Sarcoma Therapy: How Far along Are We? | Biomedicines | 2021 | 34440182 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/970/papers?page=94